Category European Commission

Commission public consultation on the revision of the EU pharmaceutical legislation

The EU Commission has published a public consultation on the revision of the EU’s pharmaceutical legislation. This is part of its work to create a future-proof and crisis-resilient regulatory framework for the pharmaceutical sector and the latest step towards an…

Read MoreCommission public consultation on the revision of the EU pharmaceutical legislation

EC issues notice on the handling of duplicate MAAs of pharmaceutical products under Article 82(1) of Regulation (EC) No 726/2004

The European Commission (EC) has issued a notice on the handling of duplicate marketing authorisation applications (MAAs) of pharmaceutical products under Article 82(1) of Regulation (EC) No 726 Basically, this means duplicate MAAs for products authorised via the centralised procedure.…

Read MoreEC issues notice on the handling of duplicate MAAs of pharmaceutical products under Article 82(1) of Regulation (EC) No 726/2004